Publication

Genomic correlates of outcome in a randomised comparison of CPX-351 and FLAG-Ida in high-risk acute myeloid leukaemia and myelodysplastic syndrome: results from the UK NCRI AML19 Trial

Othman, J.
; 
Dillon, R.
; 
Wilhelm-Benartzi, C.
; 
Knapper, S.
; 
Batten, L. M.
; 
Canham, J.
; 
Hinson, E. L.
; 
Villiers, W.
; 
Kleeman, M.
; 
Gilkes, A.
... show 9 more
Citations
Altmetric:
Abstract
Authors
Othman, J.
Dillon, R.
Wilhelm-Benartzi, C.
Knapper, S.
Batten, L. M.
Canham, J.
Hinson, E. L.
Villiers, W.
Kleeman, M.
Gilkes, A.
Potter, N.
Overgaard, U. M.
Mehta, P.
Kottaridis, P.
Cavenagh, J.
Hemmaway, C.
Arnold, C.
Dennis, Michael
Russell, N. H.
Affiliation
Department of Medical and Molecular Genetics, King's College London, London
Description
Date
2022
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Othman J, Dillon R, Wilhelm-Benartzi C, Knapper S, Batten LM, Canham J, et al. Genomic Correlates of Outcome in a Randomised Comparison of CPX-351 and FLAG-Ida in High-Risk Acute Myeloid Leukaemia and Myelodysplastic Syndrome: Results from the UK NCRI AML19 Trial. Blood. 2022 Nov;140:1036-8. PubMed PMID: WOS:000893223201017.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/626112
Embedded videos